Long-Term Care

Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.

A presentation at the Disease Prevention and Control Summit in Philadelphia, Pennsylvania, spoke about the rising threat of Candida auris.

As influenza and COVID-19 circulate in long-term care facilities, prompt testing, isolation precautions, and antiviral treatments are crucial for preventing outbreaks and protecting vulnerable residents.

Pharmacies, with their widespread locations and extended hours, have become vital access points for vaccinations, particularly in underserved communities. They provide convenience, education, and trusted health care services to millions across the US.

Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.

The 2024 surge in infectious diseases like mpox, measles, and meningitis demands a paradigm shift in control strategies, emphasizing expanded expertise, improved airborne precautions, and rethinking cost-effectiveness in healthcare to prevent future outbreaks and protect public health.

Maintaining team morale during financial instability and potential layoffs requires clear communication, emotional support, and professional development opportunities to reassure and retain valuable team members.

Here are the formal rules for the 2024 Winner of the Infection Control Today®’s Educator of the Year Award™.

Communal dining in LTC facilities enhances social interaction and nutrition but requires infection prevention measures to protect residents from risks like gastrointestinal and respiratory infections.

Balancing personal struggles and professional responsibilities during crises requires self-awareness, self-compassion, healthy boundaries, and support networks. Embrace these strategies to navigate and overcome challenges.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 20, 2024.

In a follow-up to Infection Control Today's (ICT's) article on the CDC's Antimicrobial Resistance Threats in the US 2021-2022 release, Michael Craig, MPP, director of CDC's Antimicrobial Resistance Coordination and Strategy Unit, answers ICT's questions.

Check out Infection Control Today's PowerPoint that explains updates to the long-term care enhanced barrier precautions (EBP) requirements from the CMS.

The CDC reports today of a 20% increase in antimicrobial-resistant infections during COVID-19, in the years of 2021-2022, highlighting the need for ongoing prevention and updated estimates starting in 2025.

William Shutze, MD, FACS, discusses how infection prevention impacts vascular health, emphasizing key strategies and the role of vascular surgeons in maintaining vascular well-being.

Enhanced barrier precautions (EBP) in nursing homes are vital to prevent multidrug-resistant organism (MDRO) transmission, address antimicrobial resistance, and ensure resident safety and well-being.

Dry hydrogen peroxide (DHP) significantly reduces surface bioburden in long-term care facilities, enhancing infection control and lowering volatile organic compounds, as presented by Mary L. Cole, MS, RN, CNRN, CCRN, SCRN, CIC, at APIC24.

Certification in infection prevention and control is essential for career growth, higher salaries, and improved patient outcomes. Learn why certification matters from Shazia Irum, MSC, MBA, RN, CIC, CPHQ, CBIC Ambassador in Saudi Arabia.

Amid escalating multidrug-resistant organism threats, hospitals face business risks and patient trust erosion, necessitating improved cleaning and infection prevention practices.

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

Stay informed on the growing threat of Candida auris with expert insights on its multidrug-resistance, clinical manifestations, and effective prevention strategies for health care settings.

Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.

Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.

Pfizer Inc, has released promising top-line data for its Abrysvo vaccine, demonstrating high efficacy against respiratory syncytial virus (RSV) in adults aged 60 and older. These findings from the Phase 3 clinical trial hold significant implications for infection control personnel working to combat RSV infections, especially in vulnerable populations.

Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

An interview with an infectious diseases expert on how respiratory syncytial virus (RSV) impacts populations, current treatments, and best methods for prevention.

At the Rockingham County Rehabilitation Center's Infection Control Fair, innovative and interactive approaches, including demonstrations, quizzes, and engaging activities, significantly promoted infection prevention education, making learning a fun and informative experience.

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.